Science Behind the Silent Killer

The science behind the silent killer.  Here is how Inimmune is developing vaccines to help solve the opioid epidemic. Read full article: Science and the Silent Killer

Vaccine targeting opioid addiction with Dr. Jay Evans

The University of Montana is a recipient of a $3.3 million dollar contract from the National Institutes of Health to develop a vaccine to treat opioid addiction.  Inimmune Corporation will be a collaborator in developing this project.  Watch the interview to...

The Future of Food Allergies – Developing New Treatments

Inimmune is developing vaccines to treat food allergies.  Read about the future prospects of treatments for food allergies here.